Trial
NCT00668564
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Hurler's Syndrome
Intervention
Stem Cell Transplantation
Why stopped
Replaced by another study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28